PACAP-38
Pituitary Adenylate Cyclase-Activating Polypeptide-38 is a neuropeptide with broad neurotrophic, anti-apoptotic, and neuroprotective effects. It stimulates cAMP signaling and modulates stress responses.
Protocol
Intranasal research dosing under investigation
Half-Life
~5 minutes (tissue effects prolonged)
Molecular Structure & Chemistry
11 residues • 174 atoms • Skeletal Formula
C54H87N13O18S2
1,072.33 g/mol
1269.574 Da
2.99
-1
+0.23
Amino Acid Sequence
Biological Mechanisms
Neuroprotection
Observed in clinical research as a primary mechanism of action for PACAP-38.
Enhanced neuroplasticity
Observed in clinical research as a primary mechanism of action for PACAP-38.
BDNF upregulation
Observed in clinical research as a primary mechanism of action for PACAP-38.
Anti-inflammatory in the brain
Observed in clinical research as a primary mechanism of action for PACAP-38.
Improved memory under stress
Observed in clinical research as a primary mechanism of action for PACAP-38.
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
Quick Reference
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs